GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aiobio Co Ltd (XKRX:447690) » Definitions » Debt-to-Revenue

Aiobio Co (XKRX:447690) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Aiobio Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Aiobio Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Aiobio Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Aiobio Co's annualized Revenue for the quarter that ended in . 20 was ₩0.00 Mil.


Aiobio Co Debt-to-Revenue Historical Data

The historical data trend for Aiobio Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aiobio Co Debt-to-Revenue Chart

Aiobio Co Annual Data
Trend
Debt-to-Revenue

Aiobio Co Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Aiobio Co's Debt-to-Revenue

For the Medical Devices subindustry, Aiobio Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aiobio Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aiobio Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aiobio Co's Debt-to-Revenue falls into.



Aiobio Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Aiobio Co's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Aiobio Co's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Aiobio Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aiobio Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aiobio Co (XKRX:447690) Business Description

Traded in Other Exchanges
N/A
Address
38, Teheran-ro 4-gil, 8th Floor, Gangnam-gu, Seoul, KOR, 06241
Aiobio Co Ltd manufactures products for dental checkup services. Its product includes Qraycam Pro; Qraypen C, W-Block; Qray SW; Qrayview C, Goggles; Qray m and Qscan plus.

Aiobio Co (XKRX:447690) Headlines

No Headlines